Microcap biopharmaceutical company Spherix (SPEX +105%) soars after saying that its drug...

|About: Spherix Incorporated (SPEX)|By:, SA News Editor

Microcap biopharmaceutical company Spherix (SPEX +105%) soars after saying that its drug candidate, SPX-106, achieved statistically significant reductions in VLDL and LDL cholesterol when administered to genetically engineered mice prone to dyslipidemia.